Immunotherapy: New Options in Gastrointestinal Cancers?
Visc Med
.
2019 Mar;35(1):47-51.
doi: 10.1159/000497293.
Epub 2019 Feb 14.
Authors
Andrea Tannapfel
1
,
Anke Reinacher-Schick
2
,
Ulrich Hacker
3
,
Sylvie Lorenzen
4
,
Markus Möhler
5
,
Arndt Vogel
6
Affiliations
1
Institute of Pathology, Ruhr-University Bochum, Bochum, Germany.
2
Department of Hematology, Oncology and Palliative Care, Ruhr-University Bochum, Bochum, Germany.
3
University Cancer Center Leipzig (UCCL), University Hospital Leipzig, Leipzig, Germany.
4
3rd Department of Internal Medicine (Hematology/Medical Oncology), Klinikum rechts der Isar der Technical University Munich, Munich, Germany.
5
Department of Medicine I, University Medical Center of Johannes Gutenberg University Mainz, Mainz, Germany.
6
Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
PMID:
31312650
PMCID:
PMC6597929
DOI:
10.1159/000497293
No abstract available